Breo(SH:688793) GOLDEN SUN SECURITIES·2025-05-20 03:58Investment Rating - The report maintains a "Buy" rating for the company [4][7]. Core Views - The company achieved profitability in 2024 with a net profit of 0.1 billion yuan, a year-on-year increase of 120.2% despite a revenue decline of 14.9% to 1.09 billion yuan [1][4]. - The company is exploring a new business model combining "technology products + effective massage services" to drive future growth [2]. Revenue Performance - In 2024, domestic and international revenues were 1.0 billion yuan and 0.08 billion yuan, reflecting a year-on-year decline of 16.4% and an increase of 9.5%, respectively [2]. - The revenue breakdown by product for 2024 shows significant variations, with head and neck products performing well, while eye and shoulder products saw declines [2]. Profitability Metrics - The gross margin for 2024 improved by 1.3 percentage points to 60.6%, with notable increases in margins for eye and neck products [3]. - The net profit margin for 2024 was 0.9%, an increase of 4.9 percentage points year-on-year [3]. Future Projections - The forecast for net profit from 2025 to 2027 is 0.47 billion yuan, 0.62 billion yuan, and 0.80 billion yuan, representing substantial growth rates of 358.8%, 31.4%, and 30.1%, respectively [4]. - The expected earnings per share (EPS) for 2025 is projected at 0.55 yuan, with a price-to-earnings (P/E) ratio of 56.1 [6][4].